Global Transradial Access Products Top Major Players 2025, Forecast To 2034
26 Mar, 2025
What Fueled The Previous Growth In The Transradial Access Products Market?
The transradial access products market has seen considerable growth due to a variety of factors.
• The market size for transradial access products has seen a significant expansion in the recent past. The market, which was valued at $2.20 billion in 2024, is projected to climb to $2.49 billion in 2025, growing at a compound annual growth rate (CAGR) of 12.9%.
Factors contributing to this growth over the historical period include an increase in incidences of chronic diseases, a growing aging population, a rise in cardiovascular disease cases, an increase in lifestyle-related disorders and cardiovascular diseases, and heightened awareness about the benefits of radial access.
What Can Be Expected from the Transradial Access Products Market Size?
The transradial access products market is expected to maintain its strong growth trajectory in upcoming years.
• Rapid expansion is anticipated in the transradial access products market over the forthcoming years, with expectations to reach a worth of $3.99 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.5%.
This growth during the predicted period can be ascribed to the escalating demand for minimally invasive surgical procedures, increasing cancer instances, a rise in preference for vascular access devices, and a surge in heart diseases and obesity, as well as the growing prevalence of chronic illnesses. During the forecast period, prominent trends will include technological advancements in treatments, the uptake of transradial access methods, integration of transradial access devices in routine clinical procedures, the emergence of new technology, and peripheral intervention technologies.
What Are the Critical Driver Fuelling The Transradial Access Products Market's Growth?
The rise in cardiovascular diseases is anticipated to boost the transradial access products market's expansion. These diseases, which include disorders like coronary artery disease, heart failure, and stroke, affect the heart and blood vessels. Sedentary lifestyles, unhealthy food habits, obesity, smoking, excessive drinking, and aging are factors contributing to the growing incidence of these diseases, leading to increased cases of hypertension, diabetes, and other risk factors. Transradial access products enhance the treatment of cardiovascular disorders, allowing less invasive catheterization procedures that minimize complications, enhance patient comfort, and hasten recovery periods. For example, the Australian Institute of Health and Welfare stated in December 2023 that CHD-certified deaths rose to 14,900 in 2022. Hence, the rise in cardiovascular disorders is boosting the transradial access products industry. The Surge in Obesity Cases Accelerating the Market Growth
How Is The Transradial Access Products Market segmented?
The transradial access products market covered in this report is segmented –
1) By Product: Catheter, Guidewire, Sheath, Other Products
2) By Application: Diagnostic And Interventional, Drug Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Catheter: Diagnostic Catheters, Guiding Catheters, Balloon Catheters
2) By Guidewire: Hydrophilic Guidewires, Nitinol Guidewires, Stainless Steel Guidewires
3) By Sheath: Introducer Sheaths, Radial Sheath Sets, Hydrophilic-Coated Sheaths
4) By Other Products: Hemostatic Devices, Compression Bands, Vascular Closure Devices
What Trends Are Reshaping The Future Of The Transradial Access Products Market?
Leading businesses in the transradial access products market are concentrating on the development of innovative products like peripheral support catheters to increase procedural efficiency and enhance patient results. The peripheral support catheter is a specific type of catheter that provides extra solidity and support during intricate peripheral vascular interventions, such as navigating tortuous arteries or crossing chronic total occlusions. For example, in December 2024, Terumo Interventional Systems (TIS), a subsidiary of the US medical technology company, Terumo Corporation, launched the R2P NaviCross Peripheral Support Catheter. This catheter is part of a broad portfolio of interventional products, which includes devices such as catheters, guidewires, sheaths used in cardiovascular and peripheral procedures. The R2P NaviCross Peripheral Support Catheter is designed to aid guidewires and improve navigation during complex peripheral vascular procedures, thereby enabling crossing of problematic lesions and accessing hard-to-reach areas in peripheral arteries.
Who Are the Key Players In The Transradial Access Products Market?
Major companies operating in the transradial access products market are:
• Johnson & Johnson
• Abbott Vascular
• Medtronic plc
• Becton Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• Terumo Corporation
• Edwards Lifesciences Corporation
• Teleflex Incorporated
• Cook Medical
• Biotronik SE & Co.
• Smiths Medical
• Merit Medical Systems Inc.
• Penumbra Inc.
• Angiodynamics Inc.
• Oscor Inc.
• Asahi Intecc Co. Ltd.
• Nipro Medical Corporation
• Vascular Solutions Inc.
• TherOx Inc.
What Is The Most Dominant Region In The Transradial Access Products Market?
North America was the largest region in the transradial access products market in 2024. The regions covered in the transradial access products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.